Skip to main content

Advertisement

Table 1 Baseline characteristics according to body mass index (n = 643)

From: Impact of Body Mass Index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population

Characteristics BMI < 27 kg/m2
(n = 478)
BMI ≥ 27 kg/m2
(n = 165)
p
Male, No 252 (53%) 80 (48%) NS
Age (year-old) 59 ± 11 59 ± 11 NS
EAT thickness (mm)    
   Mean ± SD 3.0 ± 2.4 3.5 ± 2.4 0.01
   Median 2.8 3.0 0.01
Body Mass Index (kg/m2) 23.7 ± 2.4 29.0 ± 2.1 < 0.001
Waist circumference (cm)    
   Male 87.0 ± 8.0 97.1 ± 7.5 < 0.001
   Female 84.7 ± 9.1 95.0 ± 7.6 < 0.001
Total cholesterol (mg/dl) 170.6 ± 35.3 182.32 ± 39.2 0.001
LDL cholesterol (mg/dl) 97.0 ± 30.0 104.4 ± 33.7 0.025
Triglyceride (mg/dl) 142.1 ± 83.3 183.1 ± 109.5 < 0.001
HDL cholesterol (mg/dl)    
   Male 44.0 ± 10.7 40.3 ± 9.2 0.013
   Female 48.3 ± 12.7 47.1 ± 11.3 NS
Fasting glucose (mg/dl) 115.0 ± 33.9 120.0 ± 43.4 NS
Hypertension, No 313 (66%) 125 (76%) 0.012
Diabetes, No 295 (62%) 128 (78%) < 0.001
Smoking, No 156 (33%) 41 (25%) 0.048
Metabolic Syndrome, No 243 (49%) 133 (81%) < 0.001
Metabolic Score 2.5 ± 1.3 3.3 ± 1.0 < 0.001
Coronary Artery Disease, No 247 (52%) 74 (45%) NS
   Normal & minimal CAD 230 (48%) 91 (55%) NS
   1 vessel 111 (23%) 31 (19%) NS
   2 vessel 69 (14%) 24 (15%) NS
   3 vessel 65 (14%) 19 (12%) NS
Medication, No    
   Aspirin 115 (24%) 37(22%) NS
   Beta blockers 49 (10%) 19 (12%) NS
   Calcium channel blockers 89 (19%) 33 (20%) NS
   ACE inhibitors 23 (5%) 4 (2%) NS
   AT II receptor blockers 58 (12%) 22 (13%) NS
   Statins 46 (10%) 22 (13%) NS
   Nitrates 51 (11%) 16 (10%) NS
   Diuretics 46 (10%) 18 (11%) NS
  1. EAT, epicardial adipose tissue; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CAD, coronary artery disease; ACE, angiotensin converting enzyme; AT, angiotensin; SD, standard deviation; NS, not significant